News | Mammography | December 08, 2017

Study of more than 130,000 mammograms shows optimal compression pressure may improve recall rates, false positives and interval cancer rates

Breast Cancer Screening Performance Impacted by Mean Mammographic Compression Pressure

December 8, 2017 — Dutch researchers demonstrated a strong relationship between compression pressure in mammography and breast cancer screening performance. Involving more than 130,000 mammograms from the Dutch Breast Screening Program and Volpara software, the study showed that very high pressure is linked with reduced sensitivity and very low pressure translates to low specificity.

The study, "Influence of breast compression pressure on the performance of population-based mammography screening," was published in the current issue of Breast Cancer Research. In this study, the data are adjusted for volumetric density and breast volume when evaluating the impact of pressure on screening performance. Katherina Holland, Nico Karssemeijer and researchers from Radboud University Medical Centre in Nijmegen, Netherlands, measured mean compression pressure for 132,776 digital mammograms. Volumetric breast density and pressure was measured using Volpara software. The data was subdivided into five quintiles of mean pressure and the number of screen-detected cancers, interval cancers, false positives and true negatives were available for each group.

The results bolster a growing body of research that suggest that mean compression pressure is related to screening performance, with compression pressures in lower ranges leading to a higher recall rate and a higher false positives fraction, and compression pressures in the higher ranges reducing detectability of breast cancer. These findings are consistent with results from the Norwegian Breast Screening Program recently published in Breast Cancer Research and Treatment.

"Lack of consistent guidelines for mammographic compression can lead to a wide variation in execution. The study shows that adequate compression pressure is crucial for obtaining high quality exams. Both very high and very low mean compression pressure can adversely affect mammography quality. Therefore, it is reasonable to suggest that standardizing to an intermediate compression pressure may lead to better screening outcomes and a better patient experience," said Karssemeijer.

For more information: www.sigmascreening.com

Related Content

News | Magnetic Resonance Imaging (MRI)

December 1, 2021 — In the first MRI-based study to investigate prenatal alcohol exposure, researchers found significant ...

Time December 01, 2021
arrow
News | Coronavirus (COVID-19)

November 30, 2021 — COVID-19 of mild to moderate severity in pregnant women appears to have no effect on the brain of ...

Time November 30, 2021
arrow
News | Computed Tomography (CT)

November 30, 2021 — A three-year study of more than 1,000 patients found that the risk of delayed intracranial ...

Time November 30, 2021
arrow
News | Coronavirus (COVID-19)

November 29, 2021 — The largest multi-institutional international study to date on brain complications of COVID-19 has ...

Time November 29, 2021
arrow
News | Artificial Intelligence

November 28, 2021 — Lunit, a medical AI provider, is returning to the 107th Radiological Society of North America (RSNA) ...

Time November 28, 2021
arrow
News | Breast Imaging

Lunit, a leading medical AI provider, announced that the U.S. Food and Drug Administration (FDA) 510(k) has cleared its ...

Time November 28, 2021
arrow
News | Breast Imaging

November 24, 2021 — Hologic Inc. will showcase its extensive portfolio of breast and skeletal health products, including ...

Time November 24, 2021
arrow
News | Flat Panel Displays

November 24, 2021 — The rise of digital imaging technology has quickly changed the way in which patient data are used ...

Time November 24, 2021
arrow
News | Coronavirus (COVID-19)

November 24, 2021 — Significant decreases in CT imaging for cancer persisted even after the peak of the COVID-19 ...

Time November 24, 2021
arrow
News | Mammography

November 23, 2021 — Siemens Healthineers has announced the U.S. Food and Drug Administration (FDA) clearance of two new ...

Time November 23, 2021
arrow
Subscribe Now